Ra Capital Management, L.p.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
85
Total Value
5952606666
Accession Number
0001104659-25-049549
Form Type
13F-HR
Manager Name
Ra Capital Management, L.p.
Data Enrichment
91% identified
77 identified8 unidentified

Holdings

85 positions
Manager:
Search and click to pin securities to the top
SERA PROGNOSTICS, INC.
Shares:
3032808(+0.0%)
Value:
$11.2B(-54.8%)
MBX Biosciences, Inc.
Shares:
1511334(+0.0%)
Value:
$11.2B(-60.0%)
BICYCLE THERAPEUTICS PLC
Shares:
1093477(+0.0%)
Value:
$9.3B(-39.4%)
Arcus Biosciences, Inc.
Shares:
1136364
Value:
$8.9B
Surrozen, Inc./DE
Shares:
679130(+140.3%)
Value:
$7.9B(+95.3%)
Immatics N.V.
Shares:
1750000(+0.0%)
Value:
$7.9B(-36.6%)
Avalo Therapeutics, Inc.
Shares:
967000(+0.0%)
Value:
$7.7B(+7.8%)
G70077105
Shares:
750000(+0.0%)
Value:
$7.7B(+1.2%)
10919W405
Shares:
206427(-55.2%)
Value:
$7.4B(-55.1%)
Aclaris Therapeutics, Inc.
Shares:
4666667(+0.0%)
Value:
$7.1B(-38.3%)
Acadia Healthcare Company, Inc.
Shares:
217000
Value:
$6.6B
08659B102
Shares:
500000
Value:
$6.1B
Xencor Inc
Shares:
575000(+0.0%)
Value:
$6.1B(-53.7%)
Werewolf Therapeutics, Inc.
Shares:
6144881(+0.0%)
Value:
$6.0B(-34.3%)
Adicet Bio, Inc.
Shares:
7541000(+0.0%)
Value:
$5.7B(-21.5%)
Humacyte, Inc.
Shares:
3312356
Value:
$5.6B
Zura Bio Ltd
Shares:
3217503(+0.0%)
Value:
$4.2B(-48.4%)
BioAge Labs, Inc.
Shares:
1052494(-19.7%)
Value:
$4.0B(-47.8%)
Boundless Bio, Inc.
Shares:
2180631(+0.0%)
Value:
$3.3B(-47.9%)
28658R106
Shares:
2479872(+0.0%)
Value:
$3.0B(-32.2%)